PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
3.82
Current Ratio above 3 – Ample short-term liquidity. Warren Buffett would check if excess cash could be redeployed effectively.
3.82
Quick Ratio above 2.5 – Very strong near-cash coverage. Warren Buffett would verify if idle resources are allocated optimally.
3.73
Cash Ratio above 2.0 – Extremely liquid. Warren Buffett would see if cash is being deployed effectively or just sitting idle.
-958.91
Negative interest coverage suggests negative EBIT or an overbearing interest burden – a major red flag for Benjamin Graham.
No Data
No Data available this quarter, please select a different quarter.